# Aczone

NDC: 16110-526
Generic name: dapsone
Labeler / Manufacturer: Almirall, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20190910

FDA application: NDA207154

## Active ingredients

- DAPSONE: 75 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16110-526"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16110-526
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22058b7d-a578-4eaa-a476-ac982337f02a